Reset filter
Nyckelord
N05.715.360.775.175.250.350 ×
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

730 Sökresultat.
Relevans Bedömning Nya först Gamla först

EWOG SAA Day +100 - Day +100

- 2014-08-06 - 1 Formulär, 2 Item-grupper, 2 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Data about day +100
Genetische und immunologische Charakterisierung der schweren aplastischen Anaemie (SAA) bei Kindern und Jugendlichen (EWOG-SAA) http://ewog-mds.org/

EWOG MDS 2006 Follow up (year {0}) DRKS00003789 - Follow up (year {0})

- 2014-08-05 - 1 Formulär, 2 Item-grupper, 4 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Follow up
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 Jahres-Follow-up (Jahr {0}) DRKS00003789 - Jahres-Follow-up (Jahr {0})

- 2014-08-05 - 1 Formulär, 2 Item-grupper, 3 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Covered period and date of documentation
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 Follow-up DRKS00003789 - Follow-up

- 2014-08-05 - 1 Formulär, 2 Item-grupper, 6 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Follow-up
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 IST FUP {0} DRKS00003789 - IST FUP {0}

- 2014-08-05 - 1 Formulär, 21 Item-grupper, 82 Dataelement, 2 Språk
Item-grupper: Show identification of patient, IST FUP, Immunosuppressive Therapy - Steroids in given interval, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - G-CSF, Complications - Infection, Complications - EBV PCR, Complications - EBV LPD, Complications - EBV LPD symptoms, Complications - EBV LPD site, Complications - EBV LPD treatment, Complications - Hemorrhage, Complications - Renal/Metabolic Lab., Creatinine, Complications - Other type of complication, Response - Transfusions, Response - Transfusion PLT, Response - Transfusion RBC, Response - Complete blood count, Response, Study centre specific variables
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 Day +100 DRKS00003789 - Day +100

- 2014-08-05 - 1 Formulär, 2 Item-grupper, 2 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Data about day +100
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

Ewing Study Nachsorgezyklus DRKS00003588 - Nachsorgezyklus

- 2014-08-04 - 1 Formulär, 3 Item-grupper, 6 Dataelement, 2 Språk
Item-grupper: Show identification of patient, Zeitpunkt der Untersuchung, Untersuchung von
EWING 2008, EudraCT 2008-003658-13, http://clinicaltrials.gov/ct2/show/NCT00824083

Breast Cancer NCT00053339 Follow-Up - CALGB: Secondary Malignancy Form - 2029264v3.0 - CALGB: Secondary Malignancy Form

- 2014-03-20 - 1 Formulär, 3 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Administrative documentation, Administrative documentation, Administrative documentation
CALGB: Secondary Malignancy Form Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D10AA-19A6-4733-E034-0003BA0B1A09

Monat 1 Erhaltungstherapie / Nachbeobachtung EudraCT-Nr.: 2008-004583-40 Akute myeloische Leukämie(AML) AML alle außer FAB M3 - Monat 1 Erhaltungstherapie / Nachbeobachtung

- 2013-12-16 - 1 Formulär, 9 Item-grupper, 79 Dataelement, 2 Språk
Item-grupper: Patientendaten, Therapie-Status, ECOG-Status, Differentialblutbild, Klinische Chemie, Knochenmarkuntersuchung, Zytologie, Molekulargenetik, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML

Nonneoplastic Condition NCT01057121 Follow-Up - AMC-070 Missed Visit Form (F35) - 3147075v1.0 - AMC-070 Missed Visit Form (F35)

- 2012-09-19 - 1 Formulär, 3 Item-grupper, 6 Dataelement, 1 Språk
Item-grupper: Header Module, Missed Visit Information, Comments
AMC-070 Missed Visit Form (F35) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E448E8-A121-E89F-E040-BB89AD433766

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial